Oxalatoplatinum
Categoria
Oxalatoplatinum Marchi, Oxalatoplatinum Analoghi
Oxalatoplatinum Marchi miscela
Oxalatoplatinum Formula chimica
Oxalatoplatinum RX link
Oxalatoplatinum FDA foglio
Oxalatoplatinum DMS (foglio di materiale di sicurezza)
Oxalatoplatinum Sintesi di riferimento
Oxalatoplatinum Peso molecolare
Oxalatoplatinum Temperatura di fusione
Oxalatoplatinum H2O Solubilita
Oxalatoplatinum Stato
Oxalatoplatinum LogP
Oxalatoplatinum Forme di dosaggio
Oxalatoplatinum Indicazione
Oxalatoplatinum Farmacologia
Oxalatoplatinum Assorbimento
Oxalatoplatinum Tossicita
Oxalatoplatinum Informazioni paziente
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
